Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Alopecia in dogs is often caused by mange, flea and tick infestations, and nutritional deficiencies, especially in males and young dogs.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Muscles and nerves that cause goosebumps also help control hair growth.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Permanent hair dye may cause total hair loss.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

Researchers found four genes that could help diagnose severe alopecia areata early.

ILC1 cells contribute to hair loss in alopecia areata.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.